Nefosar 30 mg is a non-opioid analgesic medication prescribe for the management of moderate to severe pain. It is commonly use to alleviate pain arising from various sources, including musculoskeletal disorders, dental procedures, surgical interventions, and cancer-related pain. Each tablet contains 30 mg of nefopam hydrochloride, the active pharmaceutical ingredient responsible for its analgesic properties. Nefopam functions by inhibiting the reuptake of neurotransmitters such as serotonin, dopamine, and noradrenaline, thereby disrupting pain signal transmission to the brain. Manufactured by Abbott India Pvt. Ltd., this oral tablet is generally reserved for cases where first-line pain relief options, such as paracetamol or NSAIDs, are ineffective. It is not recommended for pediatric patients under 12 years of age. Nefosar 30 mg is indicated in various clinical scenarios requiring potent analgesia. Common therapeutic uses include: Management of post-operative pain following surgical procedures. Relief of musculoskeletal and joint pain in conditions like osteoarthritis and rheumatoid arthritis. Control of dental pain, either post-operatively or due to underlying dental pathology. Pain management in oncology settings. Treatment of acute trauma or injury-related pain. By alleviating inflammation and enhancing comfort, the drug improves mobility, recovery, and overall quality of life in affected patients. Nefosar 30 mg is intend for oral administration. Patients are advised to swallow the tablet whole with water, without chewing or crushing it. Onset of pain relief typically occurs within 1 to 2 hours post-ingestion. The usual adult dose is 30 mg three times a day. Base on the patient’s clinical condition, the dose may be adjust to a maximum of 90 mg three times daily, as determined by a physician. Patients should not discontinue or alter the dose without medical consultation, particularly if they experience side effects or insufficient pain relief. Nefopam, the active component in Nefosar, interrupts pain signaling in the central nervous system by inhibiting neurotransmitter reuptake. It also blocks calcium and sodium channels in nerve pathways, thereby reducing the intensity of pain perception. This mechanism makes it particularly effective in treating severe and persistent pain. Nefosar 30 mg should be store at room temperature, ideally between 20°C and 25°C, in a cool and dry environment. Avoid exposure to moisture and direct sunlight. Store the tablets in their original airtight container to maintain their stability and efficacy. Although generally well-tolerated, Nefosar 30 mg may cause certain side effects, including: Dizziness or lightheadedness Dry mouth Difficulty urinating Confusion or disorientation Numbness or tingling sensations Hypotension Convulsions (rare) These adverse effects are usually mild and transient. However, patients should seek immediate medical attention in case of severe allergic reactions or persistent discomfort. Before initiating treatment with Nefosar 30 mg, patients should inform their healthcare provider about: Current medications, including OTC drugs, supplements, or herbal products History of liver or kidney disease Pregnancy or breastfeeding status Known hypersensitivity to nefopam Due to its potential to cause drowsiness and dizziness, patients are advise to avoid driving or operating heavy machinery while on this medication. Nefosar 30 mg is a potent, prescription-based analgesic suited for managing moderate to severe pain that does not respond to standard therapies. With its unique mechanism of action involving neurotransmitter modulation and nerve signal inhibition, nefopam offers effective pain relief across a wide range of conditions. Proper dosage, patient monitoring, and adherence to precautions are essential to ensure safe and effective treatment.
What is Nefosar 30 mg?
What is Nefosar 30 mg used for?
How to Take Nefosar 30 mg
How Does Nefosar 30 mg Work?
Storage Instructions
Potential Side Effects
Precautions and Contraindications
Conclusion
Reviews
There are no reviews yet.